Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- Global Wearable Biosensors Market Trends, Strategies and Forecast to 2036 Featuring Abbott Labs, Dexcom, Medtronic, Roche, Apple, Samsung Electronics Co., Garmin and Other Key PlayersCompanies: DexcomGarmin Ltd.Medtronic plcRoche HoldingSamsung Electronics"Wearable Biosensors Market - Global Forecast to 2036" has been added to ResearchAndMarkets.com's offering. According to the research report, the global wearable biosensors market is projected to reach USD 105.5 billion by 2036 from USD 35.5 billion in 2026, growing at a CAGR of 12.5% during the forecast period (2026-2036). The growth of this market is primarily driven by the escalating demand for continuous health monitoring, the rising prevalence of chronic diseases such as diabetes and cardiovascular conditions, and the increasing adoption of personalized healthcare solutions. Wearable biosensors are sophisticated devices that enable real-time tracking of physiological parameters, providing critical data for early disease detection and remote patient management. The global wearable biosensors market is undergoing a profound structural transformation as the healthcare industry shifts from episodic, clinic-based care toward continuous, proactive health management. This evolution is being catalyzed by the rapid miniaturization of sensing technologies and the integration of advanced data analytics and artificial intelligence into consumer wearables. The industry is witnessing a significant transition from simple activity trackers toward medical-grade diagnostic devices that can monitor complex biomarkers like glucose, blood pressure, and cardiac rhythms with high precision. Furthermore, the integration of wearable biosensors with digital health and telemedicine platforms is creating a seamless ecosystem for remote patient monitoring and virtual care delivery. This dynamic shift ensures sustained demand for non-invasive, user-friendly sensing solutions that empower individuals and healthcare providers with actionable health insights, ultimately improving clinical outcomes and reducing healthcare costs. Market Segmentation The global wearable biosensors market is segmented by biomarker type (glucose monitoring, heart rate and cardiac biomarkers, blood oxygen [SpO2] monitoring, blood pressure monitoring, lactate and performance biomarkers, and other biomarkers), product type/form factor (smartwatches, fitness bands, continuous glucose monitoring devices, wearable ECG monitors, smart patches, smart rings, and smart clothing), application (clinical and medical, fitness and wellness, and sports and performance monitoring), end-user (hospitals and clinics, home care settings, fitness and sports organizations, individual consumers, and research institutions), and geography. The study evaluation includes industry competitors and analyzes the market at the country level. Based on Biomarker Type By biomarker type, the glucose monitoring segment is expected to hold the largest share of the global wearable biosensors market in 2026. This dominance is attributed to the high and rising prevalence of diabetes globally and the widespread adoption of continuous glucose monitoring (CGM) systems that eliminate the need for frequent finger-prick testing. Conversely, the heart rate and cardiac biomarkers segment is projected to register significant growth, driven by the increasing integration of ECG and heart rate variability (HRV) sensing into consumer smartwatches, enabling early detection of arrhythmias and other cardiovascular conditions. Furthermore, the lactate and multi-analyte biosensors segments are projected to register the highest CAGR during the forecast period, fueled by the growing demand for performance optimization in sports and the development of non-invasive sensors for comprehensive metabolic health tracking. Based on Product Type / Form Factor By product type/form factor, the smartwatches with integrated biosensors segment is expected to hold the largest share of the global wearable biosensors market in 2026. Smartwatches have become the primary platform for health monitoring due to their high consumer acceptance, multi-functionality, and the continuous addition of medical-grade sensors by leading tech companies. Meanwhile, the continuous glucose monitoring devices segment is projected to register the highest CAGR during the forecast period. This rapid growth is driven by the shift toward proactive diabetes management and the expansion of CGM use among non-insulin-dependent patients and health-conscious individuals. Additionally, smart patches and smart rings are emerging as high-growth segments, offering discrete and specialized monitoring for clinical and wellness applications. Based on Application By application, the clinical and medical segment is expected to hold the largest share in 2026. The increasing use of wearable biosensors for chronic disease management, post-operative monitoring, and clinical trials drives this segment's leadership. Within this segment, remote patient monitoring (RPM) is a major growth catalyst. Conversely, the fitness and wellness segment is projected to register a steady growth rate, driven by the increasing consumer focus on preventive health and the popularity of activity and sleep tracking. The sports and performance monitoring segment is also witnessing rapid expansion as professional athletes and fitness enthusiasts adopt biosensors to optimize training and recovery through data-driven insights. Based on End-User By end-user, the hospitals and clinics segment is expected to hold the largest share in 2026, reflecting the primary role of healthcare providers in prescribing and managing medical-grade wearable sensors for patient care. Conversely, the home care settings segment is projected to register the highest CAGR during the forecast period. This rapid growth is driven by the global trend toward decentralized healthcare and the increasing preference for monitoring patients in their home environments to improve comfort and reduce hospital readmissions. The individual consumers segment also remains significant, as more people purchase wearables for personal health and fitness tracking. Geographic Analysis In 2026, North America is expected to account for the largest share of the global wearable biosensors market. The region's leadership is underpinned by a highly advanced healthcare infrastructure, high levels of digital health literacy, and the presence of industry leaders such as Abbott, Dexcom, Apple, and Medtronic in the United States. Furthermore, the early adoption of remote patient monitoring and a favorable reimbursement landscape for digital health technologies contribute to the market's dominance. Key companies in the North America market include Abbott Laboratories (U.S.), Dexcom, Inc. (U.S.), Apple Inc. (U.S.), Medtronic plc (Ireland), Garmin Ltd. (U.S.), Google LLC (Fitbit - U.S.), Masimo Corporation (U.S.), VitalConnect, Inc. (U.S.), and Biolinq Inc. (U.S.). Asia-Pacific is projected to witness the fastest growth during the forecast period. This expansion is primarily driven by increasing healthcare expenditure, the rapid expansion of the middle-class population, and the high penetration of smartphones and wearable devices in China, India, and Japan. Furthermore, the rising burden of chronic diseases in the region and government initiatives to promote digital health are significant catalysts. Key companies in the Asia-Pacific market include Samsung Electronics Co., Ltd. (South Korea) and various emerging local MedTech startups. Europe remains a critical market for wearable biosensors, characterized by a strong focus on preventive healthcare and the implementation of robust medical device regulations. European countries are increasingly adopting wearable sensors to address the healthcare needs of an aging population and to improve the efficiency of public health systems. The region's focus on data privacy and security is driving the demand for sensors that comply with strict GDPR and MDR standards. Key companies in the Europe market include F. Hoffmann-La Roche Ltd. (Switzerland), Oura Health Ltd. (Finland), and Empatica Inc. (U.S./Italy). Latin America is an emerging market for wearable biosensors, driven by the modernization of healthcare facilities and the increasing adoption of consumer health technologies in Brazil and Mexico. The region is seeing a shift toward more accessible health monitoring solutions as enterprises and individuals seek to manage chronic conditions more effectively. The Middle East & Africa region is experiencing growing interest in wearable biosensors as part of national digital health transformation strategies, particularly in the UAE and Saudi Arabia. Investments in high-tech healthcare infrastructure and the adoption of AI-driven health solutions are expected to be major drivers of market growth in the region. Key Players The key players operating in the global wearable biosensors market include:
- Direct Drive Tech Limited, The Robotics Technology Company with Direct Drive Technology as Core Capability, Announces its Plan to List on the Main Board of the Hong Kong Stock Exchange, Offer Price of HK$21.60 per ShareHONG KONG, Sept 21, 2026 - Direct Drive Tech Limited (the “Company”, stock code: 06731) announces its Global Offering and the listing of Shares on the Main Board of The Stock Exchange of Hong Kong Limited (the “Hong Kong Stock Exchange”). According to the listing documents, Direct Drive Tech Limited is a robotics technology company with direct drive technology as company’s core capability. Company primarily engage in the sales of robotic actuator modules, and to a lesser extent, robots, in China. Company operate in (i) PRC consumer robotic actuator module industry, a sub-segment representing 26.3% of PRC robotic actuator module industry and (ii) PRC wheel-legged and PRC dual-wheel-legged robot industry in China, sub-segments representing less than 1.0% of the PRC robot industry. Company serve subsegments of the PRC robotic actuator module industry and PRC robot industry, specifically (i) PRC consumer robotic actuator module industry and (ii) PRC wheel-legged robot industry. From company’s inception to June 30, 2026, company’s robotics technology has empowered over 7.5million robots across consumer, industrial and commercial application scenarios, as well as embodied intelligence robots. Direct Drive Tech Limited plans to offer an aggregate of 50,000,000 Shares (subject to the Over-allotment Option) under the Global Offering, of which 47,500,000 Shares (subject to reallocation and the Over-allotment Option) will be offered by way of International Offering, and 2,500,000 Shares (subject to reallocation) will be offered in the Hong Kong Public Offering. The Offer Price will be HK$21.60 per Offer Share, with the board lot size of 100 shares. The Hong Kong Public Offering commenced on Monday, 21 September 2026 and is expected to close at 12:00 noon (at 11:30 a.m. for completing electronic applications under the White Form eIPO service) on Thursday, 24 September 2026. Dealings in H Shares on the Stock Exchange are expected to commence on Tuesday, 29 September 2026. Direct Drive estimates that company will receive net proceeds from the Global Offering of approximately HK$982.5 million, after deducting underwriting commissions, fees and estimated expenses payable by us in connection with the Global Offering, assuming the Over-allotment Option is not exercised and an Offer Price of HK$21.60 per Offer Share. The company intend to use the net proceeds of the Global Offering for the following purposes: approximately 50.0%, or HK$491.3 million, will be used to enhance R&D capabilities in key robotics technologies; approximately 20.0%, or HK$196.5 million, will be used to deepen collaboration with industry partners and broaden sales network; approximately 20.0%, or HK$196.5 million, will be used for improving production capability and efficiency; approximately 10.0%, or HK$98.3 million, will be used for working capital and general corporate purposes. The Company has successfully procured HK Technology Innovation and JSC International (for and on behalf of Shenghai SP) as cornerstone investors, the Cornerstone Investors have agreed to, subject to certain conditions, subscribe, or cause their designated entities to subscribe, at the Offer Price, for such number of Offer Shares (rounded down to the nearest whole board lot of 100 H Shares) that may be purchased for an aggregate amount of approximately HK$472.0 million (the “Cornerstone Placing”). CITIC Securities (Hong Kong) Limited is the sole sponsor. CLSA Limited serves as sponsor and Overall Coordinator. The joint global coordinators, joint bookrunners, joint lead managers and capital markets intermediaries comprise CLSA Limited, China Harbour International Securities Limited, CMB International Capital Limited and Futu Securities International (Hong Kong) Limited. Neutral Financial Holding Company Limited as an additional joint bookrunner, joint lead manager and capital markets intermediary. About Direct Drive Tech Limited Direct Drive Tech Limited was established in 2020 and is a "little giant" enterprises. As a Globally Leading Robotics Technology Company With direct drive technology as core capability, Adhering to the corporate mission of "bringing robots into every household", Direct Drive Tech is committed to making robots more efficient, dexterous and intelligent. The company currently boasts a team of over 400 members, including several Ph.D. holders and dozens of master's degree holders, with over 40% being R&D personnel, The Company has formed three major robot technology platforms: (1) The robotic actuator module technology platform; (2) The wheel-legged robot technology platform; (3) The modular reconfiguration technology platform.
- MSITEK GlobalMSITEK Participates in New York Fashion Week Retail Innovation LabMSITEK , Global SAP partner and digital transformation company, participated in the Retail Innovation Lab by NYFW Collections and SAP in New York during New York Fashion Week (NYFW). As an innovative SAP partner invited to participate, MSITEK...
- Sinoexpo Informa MarketsHotel & Shop Plus 2027: Seamless Synergy across Design, Sustainability, DigitalizationOrganized by Sinoexpo Informa Markets and leading Chinese and international industry organizations, Hotel & Shop Plus Shanghai 2027, the leading trade fair for the hotel, retail, office and public-space industries, is scheduled for March 30–April...
- Wearable Sleep Trackers Market Grows as AI Analytics Push Consumer Devices Toward Clinical-Grade MonitoringAs per SNS Insider, the Global Wearable Sleep Trackers Market is projected to reach USD 48.60 billion by 2035, growing at a 11.20% CAGR, while the U.S. market is projected to reach USD 18.59 billion, advancing at 10.90% CAGR, as multi-sensor fusion and machine learning extend sleep monitoring into clinically adjacent, preventive health applications.
- Insta360Insta360 Opens First Flagship Store Outside Asia In New York's Times Square Amid Global Retail ExpansionInsta360 officially opened its first flagship retail store outside of Asia on Saturday, September 19, 2026, occupying a prime location at 1515 Broadway in New York's Times Square. The store opening marks a major milestone in the global imaging...
- Native Springs Expands Smart Home Technology Coverage with New 2026 Consumer ResourceNative Springs has announced an expansion of its consumer technology coverage with the publication of a new 2026 smart-home resource examining connected devices used for household automation, security, cleaning, energy monitoring and climate control. The publication forms part of the website’s developing coverage of consumer technology and connected-home systems.
- AmazonAmazon highlights investments in satellite connectivity, responsible AI, and sustainability at UN General AssemblyCompanies: AmazonFrom satellite internet in South Africa to 42 gigawatts of clean energy, Amazon's Chief Global Affairs Officer shares how the company is investing in the future.
- Newmark Group, Inc.Newmark Arranges Financing for Related Ross' Acquisition of Landmark 1.7 MSF Boca Raton Innovation CampusVision for Former IBM Campus Includes Mix of Amenities, Retail and Restaurants — Newmark Group, Inc. (Nasdaq: NMRK) ("Newmark" or the "Company"), a leading commercial real estate advisor and service provider to large institutional investors, global...
- Coresight Research Hosts One-Day Conference Examining AI Impact and Strategies for the Retail IndustryNEW YORK, September 18, 2026--Coresight Research, the leading research and advisory firm specializing in retail and technology, in partnership with Tractor Supply and Soles4Souls, announces Coresight Conference: How AI Is Redefining The Possible, a one-day conference taking place September 28, 2026, in Nashville, TN. Coresight Conference creates an opportunity for retail executives and technology leaders to examine how artificial intelligence has impacted brands, retailers, and consumers, and sh
- FAO SchwarzFAO SCHWARZ BRINGS ITS ICONIC TOY STORE EXPERIENCE TO AMAZON.COM THIS FALLCompanies: AmazonFAO Schwarz launched its first-ever Amazon storefront, offering customers in the U.S. a new way to shop its collections and enjoy the brand experience — The FAO Schwarz legacy of wonder and awe is now available on Amazon.com, along with a...
- Non-GMO ProjectNon-UPF Verified Surpasses 300 Products as Demand for Food Processing Transparency GrowsProgram introduces a new consumer app that lets shoppers scan products, learn about food processing and ask their favorite brands to pursue verification — Since opening for enrollment on January 21, 2026, the Non-UPF Verified program has...